Literature DB >> 27199001

Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.

Si-Jia Wu1, Yi-Xin Lin1, Hui Ye1, Fu-Yu Li1, Xian-Ze Xiong1, Nan-Sheng Cheng1.   

Abstract

INTRODUCTION: Lymphocytes are an integral part of lymphocyte to monocyte ratio (LMR) and prognostic nutritional index (PNI). Both LMR and PNI which reflect body's inflammatory and nutritional status can be obtained from routine blood and biochemical test conveniently. Little evidence concerning the prognostic value of LMR and PNI in hepatocellular carcinoma (HCC) patients has been published. This study aimed to investigate the prognostic value of LMR and PNI in hepatitis B virals (HBV)-associated HCC patients who underwent curative hepatectomy.
METHODS: Between January 2008 and June 2013, 450 surgically treated HCC patients were retrospectively analyzed. Clinicopathological parameters, LMR and PNI were collected and compared. The multivariate analysis was performed to indentify independent prognostic factors. Overall survival (OS) and recurrence-free survival (RFS) rates were also compared.
RESULTS: Tumor size, vascular invasion, alpha fetoprotein level, LMR and PNI were independent prognostic factors for OS. Tumor number, tumor size, vascular invasion, LMR and PNI were independent prognostic factors for RFS. Either a high LMR or PNI could predict favorable OS and RFS in surgically treated HCC patients and vice versa.
CONCLUSIONS: Both LMR and PNI were significant independent predictors that can predict survival outcomes in HBV-associated HCC patients who received curative hepatectomy. J. Surg. Oncol. 2016;114:202-210.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatocellular carcinoma; liver resection; lymphocyte to monocyte ratio; prognostic factor; prognostic nutritional index

Mesh:

Year:  2016        PMID: 27199001     DOI: 10.1002/jso.24297

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  27 in total

1.  Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.

Authors:  Jian Zheng; Deborah Kuk; Mithat Gönen; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Michael I D'Angelica; William R Jarnagin; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2016-12-05       Impact factor: 5.344

2.  Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.

Authors:  Z-X Lin; D-Y Ruan; C-C Jia; T-T Wang; J-T Cheng; H-Q Huang; X-Y Wu
Journal:  Clin Transl Oncol       Date:  2019-06-14       Impact factor: 3.405

3.  A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase.

Authors:  Jia-Si Zhang; Zhi-Heng Wang; Xing-Gang Guo; Ji Zhang; Jun-Sheng Ni
Journal:  J Gastrointest Oncol       Date:  2022-02

4.  Relationship of immunonutritional factor with changes in liver volume after portal vein embolization.

Authors:  Atsushi Nanashima; Yukinori Tanoue; Koichi Yano; Masahide Hiyoshi; Naoya Imamura; Takeomi Hamada; Kengo Kai; Eiji Kitamura; Yasuto Suzuki; Kousei Tahira; Fumiya Kawano; Takeshi Nagayasu
Journal:  Surg Open Sci       Date:  2022-05-28

5.  Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib.

Authors:  Yeonjung Ha; Mohamed A Mohamed Ali; Molly M Petersen; William S Harmsen; Terry M Therneau; Han Chu Lee; Baek-Yeol Ryoo; Sally Bampoh; Kenneth A Valles; Mohamad Mady; Venkata R Missula; Kritika Prasai; Lewis R Roberts; Kang Mo Kim
Journal:  Hepatol Int       Date:  2020-08-01       Impact factor: 6.047

6.  Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.

Authors:  Norifumi Iseda; Shinji Itoh; Tomoharu Yoshizumi; Takahiro Tomiyama; Akinari Morinaga; Tomonari Shimagaki; Huanlin Wang; Takeshi Kurihara; Takeo Toshima; Yoshihiro Nagao; Noboru Harada; Yoshinao Oda; Masaki Mori
Journal:  Int J Clin Oncol       Date:  2021-07-12       Impact factor: 3.402

Review 7.  Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis.

Authors:  Jingwen Zhang; Lishan Chen; Rui Zhou; Huiying Sun; Yulin Liao; Wangjun Liao
Journal:  Gastroenterol Res Pract       Date:  2016-08-09       Impact factor: 2.260

8.  The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib.

Authors:  Guillaume Conroy; Julia Salleron; Arthur Belle; Mouni Bensenane; Abdelbasset Nani; Ahmet Ayav; Didier Peiffert; Anthony Lopez; Cédric Baumann; Hélène Barraud; Jean-Pierre Bronowicki
Journal:  Oncotarget       Date:  2017-09-30

9.  Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancer.

Authors:  Weiwei Zhang; Bin Ye; Weijiang Liang; Yazhou Ren
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

10.  Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy.

Authors:  Meilong Wu; Shizhong Yang; Xiaobin Feng; Chengquan Li; Xiangchen Liu; Zhenyu Zhang; Ying Xiao; Chuchu Liu; Jiahong Dong
Journal:  J Inflamm Res       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.